Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics.
about
Global variation in copy number in the human genomeStructure and Protein-Protein Interactions of Human UDP-GlucuronosyltransferasesThe effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.The UGT73C5 of Arabidopsis thaliana glucosylates brassinosteroids.Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancerMutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.UGT genomic diversity: beyond gene duplication.PharmGKB summary: ibuprofen pathways.Identification of gene co-expression clusters in liver tissues from multiple porcine populations with high and low backfat androstenone phenotype.Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.Red wine and component flavonoids inhibit UGT2B17 in vitro.Identification and functional characterization of a novel UDP-glucuronosyltransferase 2A1 splice variant: potential importance in tobacco-related cancer susceptibility.The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.Quantitative determination of common urinary odorants and their glucuronide conjugates in human urine.Structure-activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferases.Sterol glycosyltransferases--the enzymes that modify sterols.Substrate selectivity of human intestinal UDP-glucuronosyltransferases (UGTs): in silico and in vitro insights.Effects of Dietary Components on Testosterone Metabolism via UDP-Glucuronosyltransferase.Transcriptional regulation of human UDP-glucuronosyltransferase genes.Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride.Determination of stanozolol and 3'-hydroxystanozolol in rat hair, urine and serum using liquid chromatography tandem mass spectrometry.UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study.Increased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion.CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR.Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.Glucuronidation of aurantio-obtusin: identification of human UDP-glucuronosyltransferases and species differences.Metabolism of megestrol acetate in vitro and the role of oxidative metabolites.Identification of UDP-glucuronosyltransferase isoforms involved in hepatic and intestinal glucuronidation of phytochemical carvacrol.Effect of UGT2B17 deletion polymorphism on prognosis in pediatric cancer.Inhibitory Effects of Diclofenac on Steroid Glucuronidation In Vivo Do Not Affect Hair-Based Doping Tests for Stanozolol.A large electronic-health-record-based genome-wide study of serum lipids.A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation.
P2860
Q24658083-C13D918F-B40B-4DC4-8B06-53EFA93068FFQ28071266-A7993A5C-D995-442A-BF45-21201AA53A3CQ33724160-47DE3EFD-0F1B-4F33-992F-CFF203CB64FCQ33878751-35B3D354-A54B-4909-8551-521F58C11304Q34084978-C2CDEFF7-AD80-4922-9368-C4063E942474Q34094975-97F362DA-9144-4143-AF38-000367A11915Q34496694-3613F5C3-268A-4B67-8EB7-C0BDCF3B0938Q34964392-37C0EF5E-BF79-407D-B761-87EC81AF88CEQ35009521-7636AA11-6422-4772-AA63-B0C40355FBABQ35164718-E83EB4E5-3EC4-4A8F-8E3F-98721B09719CQ35195263-023F4953-ED94-4F5E-933B-55743F90521FQ36353657-93656918-9E79-40A5-B5EC-1261792462C4Q36391822-A2669A13-A53E-43BF-81E2-D4C2DFE0D9AEQ36406279-28AA3E13-296A-4C67-9743-10E97956F4A2Q36940977-EE9002B7-0D5F-47BC-AC9F-2DC860204C22Q37512783-7DE6B124-573F-4E3E-BC93-253007CC664FQ37575653-F014F8C6-DE78-41F9-A8C7-E734A50B05F4Q37862116-36E417AC-D7E3-4CA5-AAED-19D32202931BQ38086603-0AF7EA32-C9F5-4590-9018-0410EA1A44F7Q38121072-137546F5-9CEC-432D-85BF-031110EF7722Q38261875-0F8D607F-E137-4261-B384-7508FC4CE8B6Q39868674-3C287485-A45F-4CB3-954E-69F7E082B478Q40505369-728B4E7A-3972-4E4A-B1A5-F84DFF6EB139Q42060254-9520A724-2696-4813-B23C-D731E7CA8830Q42067941-BFFB81FF-2AF0-4501-ACE5-7A33E6526EE8Q43434851-7A5365C3-A61E-4C89-B263-A5DB855DEF6FQ43756038-91FC4BC3-FAA4-4BA6-B6CF-85958FBC1596Q45153204-6E123ACD-2148-42D0-B42F-AA1C8A81DEE7Q46920820-4BC9B49C-7DC1-4A79-9083-18E5836398B4Q47758592-24C71156-81DA-4420-929A-6F21C77CEF0DQ48165186-9081A7D5-42C7-4616-8EF2-7BCF3485A158Q51349552-8AF4FA65-E7A8-4741-AC69-125DBC212C45Q52860574-B3BA9418-717E-451B-8A02-B7863BE16150Q53700633-CDAEDBA0-8B7A-4B15-AFCE-F8266C54F965Q54672071-A4DF5CF0-9DF1-4EF6-8B80-97E613E9EAD1
P2860
Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics.
@en
type
label
Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics.
@en
prefLabel
Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics.
@en
P2093
P356
P1476
Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics.
@en
P2093
Alain Bélanger
David Turgeon
Jean-Sébastien Carrier
Sarah Chouinard
P304
P356
10.1124/DMD.31.5.670
P577
2003-05-01T00:00:00Z